Bank of America
HURA

Bank of America’s TuHURA Biosciences HURA Stock Holding History

Bank of America’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99.5K Sell
42,506
-35,636
-46% -$83K ﹤0.01% 5531
2026
Q1 		$140K Buy
78,142
+15,135
+24% +$18.5K ﹤0.01% 5460
2025
Q4 		$47.6K Buy
63,007
+55,581
+748% +$106K ﹤0.01% 5860
2025
Q3 		$18.4K Sell
7,426
-1,447
-16% -$3.81K ﹤0.01% 7083
2025
Q2 		$19.8K Sell
8,873
-9,867
-53% -$33.3K ﹤0.01% 7065
2025
Q1 		$60.5K Buy
18,740
+4,426
+31% +$16.3K ﹤0.01% 6684
2024
Q4 		$58.5K Buy
14,314
+14,301
+110,008% +$76K ﹤0.01% 6586
2024
Q3 		$89 Sell
13
-52
-80% -$387 ﹤0.01% 7740
2024
Q2 		$612 Buy
+65
New +$405 ﹤0.01% 7318
2023
Q4 		– Sell
-6
Closed -$808 – 8267
2023
Q3 		$808 Buy
+6
New +$885 ﹤0.01% 7263
2023
Q1 		– Hold
0
– -$7 – 8349
2022
Q4 		– Hold
0
– – – 8116
2021
Q4 		– Hold
0
– – – 8720
2021
Q3 		– Hold
0
– – – 8447
2021
Q2 		– Hold
0
– – – 8152

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Bank of America's HURA Position: Q2 2026 in Review

Bank of America reduced its TuHURA Biosciences (HURA) stake by 46% in Q2 2026, selling an estimated $83K and leaving 42,506 shares worth $99.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5531.

Bank of America first reported a position in HURA in Q3 2023 and has held it in 10 quarters since. The position peaked at $140K in Q1 2026. 89 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Bank of America held 42,506 shares of TuHURA Biosciences worth $99.5K as of Q2 2026.
  • Bank of America sold 35,636 TuHURA Biosciences shares in Q2 2026, an estimated $83K.
  • TuHURA Biosciences made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #5531 holding.
  • Bank of America first reported a position in TuHURA Biosciences in Q3 2023 and has held it in 10 quarters since.
  • Bank of America's TuHURA Biosciences position peaked at $140K in Q1 2026.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.